We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current AXIM market cap is 2.29M. The company's latest EPS is USD -0.0117 and P/E is -0.85.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 60k | 9k | 39k | 78k |
| Operating Income | -4.95M | -8.01M | -4.65M | -2.75M | -1.76M |
| Net Income | -6.29M | -16.03M | -6.24M | -8.06M | -3.52M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 11.31M | 5.32M | 4.21M | 4.12M | 3.45M |
| Total Liabilities | 9.75M | 7.66M | 9.04M | 11.78M | 13.87M |
| Total Equity | 1.57M | -2.34M | -4.83M | -7.66M | -10.42M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.22M | -2.49M | -2.04M | -1.03M | -855k |
| Investing | 10k | -50k | -9k | N/A | -3k |
| Financing | 3.15M | 2.53M | 1.65M | 1.14M | 702k |
| Market Cap | 2.29M |
| Price to Earnings Ratio | -0.85 |
| Price to Sales Ratio | 33.33 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | -0.29 |
| Dividend Yield | - |
| Shares Outstanding | 301.96M |
| Average Volume (1 week) | 217.54k |
| Average Volume (1 Month) | 188.45k |
| 52 Week Change | -40.31% |
| 52 Week High | 0.019 |
| 52 Week Low | 0.0013 |
| Spread (Intraday) | 0 (24.36%) |
| Company Name | Axim Biotechnologies Inc (PK) |
| Address |
401 ryland st reno, nevada 89502 |
| Website | https://www.aximbiotech.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
